Advances in eye-care research and diagnostic technology continue to expand our understanding of disease processes and improve treatment options. Significant progress in ocular surface disease, myopia management, and dry age-related macular degeneration (dARMD) has led to meaningful changes in how we diagnose and care for patients.
Myopia Management. The FDA recently cleared Stellest® lenses by Essilor® to help slow the progression of myopia in children. Myopia rates have risen steadily over the past 50 years, with an estimated 30% of children currently affected and projections nearing 40% by 2050. Clinical studies show Stellest® lenses can reduce myopia progression by up to 67%. Additional treatment options include orthokeratology, specially designed daily soft contact lenses, and low-dose atropine eye drops. Dr. Wilder evaluates each child individually to determine the most appropriate management plan.
Dry Age-Related Macular Degeneration. For many years, dry ARMD management has focused on lifestyle modifications, nutritional supplements, smoking cessation, and close monitoring. While treatments for wet ARMD have advanced, options for slowing dry ARMD progression have been limited—until recently. The FDA has now authorized Low Light Level Therapy (LLLT), a form of photobiomodulation that supports healthier retinal function. Coastal Family Eyecare is pleased to offer LLLT as a safe, noninvasive option that may reduce progression and, in some cases, help reverse early damage, lowering the risk of conversion to wet ARMD.
Ocular Surface Disease / Dry Eye Disease Often referred to broadly as dry eye disease, ocular surface disease is a complex condition that can cause burning, itching, watering, fluctuating vision, irritation, and pain. Because the tear film is intricate, Dr. Wilder performs a comprehensive evaluation that includes assessing oil and water balance, eyelid structure and function, inflammation, allergies, rosacea, environmental influences, and systemic contributors.
Treatment options range from traditional therapies—such as lubricants, lid hygiene, punctal plugs, and topical or oral medications—to advanced interventions including amniotic membranes, LLLT, IPL, serum tears, and scleral lenses. Although dry eye cannot be cured, early and consistent treatment is essential to prevent long-term damage and preserve quality of life.